What is Biokript (BKPT) crypto coin? Facts, risks, and why it’s not worth investing in

What is Biokript (BKPT) crypto coin? Facts, risks, and why it’s not worth investing in

Biokript Investment Calculator

This tool helps you understand the potential losses of investing in Biokript (BKPT), the cryptocurrency discussed in the article. Based on real data from the article, BKPT has $0 market cap and minimal trading volume. This calculator shows how your investment would be affected by its current market conditions.

Important Note: Biokript (BKPT) is not listed on any major exchange. Current trading volume is only $27.86 daily, and the market cap is $0. This tool demonstrates why investing in such tokens is extremely risky.

Biokript (BKPT) sounds like it could be the next big thing in crypto - a hybrid exchange, Shariah-compliant, powered by Solana, with a 50/50 profit-sharing model. But if you dig deeper, the reality is far from the hype. As of December 2025, BKPT is a token with virtually no market presence, zero trading volume on major platforms, and red flags all over its claims.

What Biokript claims to be

The Biokript website says it’s the world’s first hybrid cryptocurrency platform that blends centralized and decentralized exchange features. It claims to let users trade without KYC, with AI-driven trades, anti-rug mechanisms, and one-click buying. The big selling point? Fifty percent of all trading fees go straight to BKPT token holders. That’s more than Binance gives to BNB holders, and way above what most tokens offer.

It also says it’s Shariah-compliant, meaning it’s designed for Muslim investors who avoid interest and speculative trading. And it mentions a partnership with Microsoft for security - something you’d expect to see in press releases or Microsoft’s official partner list. You won’t find either.

The token runs on Solana. That’s not a bad thing. Solana has real projects with real usage. But BKPT doesn’t seem to be one of them.

The numbers don’t add up

Here’s the cold truth: as of December 2025, Binance - one of the largest crypto exchanges in the world - explicitly states that BKPT is not listed for trading or services. That’s not a technical error. That’s a warning.

CoinGecko shows a 24-hour trading volume of just $27.86. For context, Binance alone does over $28 billion in volume every day. That’s more than a billion times more. BKPT’s market cap is listed as $0. The circulating supply? Also $0. That means no one is actually holding or trading this token in any meaningful way.

Its all-time high was $0.010586. Today, it’s trading at $0.000104. That’s a 99.02% drop. If you bought at the peak, you’d need the price to go up 10,000% just to break even. And there’s no sign that’s happening.

The profit-sharing claim is impossible

The 50/50 profit-sharing model is the main hook. But here’s the problem: if the platform has $0 in trading volume, it has $0 in fees. And if it has $0 in fees, it can’t pay out 50% to anyone. That’s basic math. One Reddit user put it bluntly: “How can they share 50% of profits when Binance shows $0 trading volume? This math doesn’t work.”

Even if you assume the token is trading on small, obscure DEXs, the volume is too low to generate any real revenue. The platform can’t pay out what it doesn’t earn. And there’s zero public accounting or blockchain-based proof of payouts.

The Microsoft and patent claims are smoke and mirrors

Biokript says it uses Microsoft technology for “cutting-edge security.” But Microsoft doesn’t list Biokript as a partner. There’s no press release. No technical documentation. No Azure integration logs you can check. This is a common tactic used by low-effort crypto scams - name-drop a big company to seem legitimate.

It also claims to have a “pending U.S. utility patent” for its hybrid exchange system. That’s meaningless. A pending patent is not a granted patent. It’s just a form you filed. Thousands of crypto projects file patents that never get approved - and even if they did, a patent doesn’t mean the technology works or is used. U.S. patent attorney David Boundy has said that crypto patent applications are often vague, overly broad, and rarely stand up to scrutiny.

A shady figure flees with presale funds as investors' NFTs turn to smoke in a cartoonish scene.

Whale NFT program? Users say they got ripped off

Biokript’s website promotes a “Whale NFT” program. Buy an NFT, get trading credits equal to your investment. Sounds fair, right?

Not according to users. On the official Biokript Telegram channel, people report buying $2,000 worth of NFTs - only to find they can’t redeem their credits. Some say they’ve messaged support for months and never got a reply. No refund. No explanation. Just silence.

Trustpilot has zero reviews. CoinGecko has three ratings averaging 1.3 out of 5. Comments like “Token shows on explorers but no real exchange listings” and “Presale promises don’t match reality” are common.

Why it’s not Shariah-compliant - even if it says it is

The claim of being Shariah-compliant sounds appealing. But Shariah compliance isn’t something you can just declare. It requires review and certification by recognized Islamic finance authorities. No such certification exists for Biokript.

Compare that to Islamic Coin (ISLM), which has actual backing from scholars and a $42 million market cap. Biokript’s use of the term feels like a marketing trick to attract a niche audience without any real religious or ethical foundation.

It’s not on any major exchange - and that’s a huge red flag

If a crypto project is legitimate, it gets listed on at least one major exchange. Binance, Coinbase, Kraken, KuCoin - these are the gateways to real liquidity. BKPT isn’t on any of them.

Binance has delisted 178 tokens since 2023 for regulatory, liquidity, or fraud concerns. The fact that BKPT isn’t even listed - and they explicitly say it’s not for trading - tells you everything you need to know. Major exchanges don’t list tokens that are dead on arrival. They don’t list tokens with $0 market cap. They don’t list tokens with no trading volume.

A tiny, abandoned Biokript shack sits ignored beside major crypto exchanges in a vibrant cartoon city.

What you’d need to do to trade BKPT

If you still want to buy BKPT, you’d have to use a small decentralized exchange (DEX) on Solana - likely one with no user reviews, no security audits, and no customer support. You’d need a Solana wallet, some SOL for gas, and the exact contract address (0x6448...B25113). But even then:

  • You’ll face massive slippage - even small trades could cost you 20% or more.
  • You won’t be able to sell easily - there’s almost no buyer demand.
  • You’re at risk of rug pulls, fake liquidity pools, or smart contract exploits.

How this compares to real hybrid exchanges

Real hybrid platforms like Coinbase or Injective Protocol have:

  • Market caps in the billions
  • Millions of users
  • Regulatory compliance
  • Public financial reports
  • Verified team members
  • Active GitHub repositories
Biokript has none of that. It has a website, a token address, and a bunch of bold claims. That’s it.

Is Biokript a scam?

It’s not officially labeled a scam by regulators - because regulators don’t waste time on projects this small. But everything about it matches the pattern of a pump-and-dump or exit scam:

  • Massive price drop from all-time high
  • $0 market cap and trading volume
  • No real exchange listings
  • Unverifiable partnerships
  • Unrealistic profit-sharing claims
  • Community complaints with no resolution
  • Zero transparency
It’s not just a failed project. It’s a project that never had a chance. The team likely raised funds during a presale, then disappeared.

Final verdict: Avoid Biokript (BKPT)

There’s no scenario where buying BKPT makes sense. Not as an investment. Not as a trade. Not even as a curiosity. The token has no utility, no liquidity, no credibility, and no future.

If you see someone promoting it on Telegram or YouTube as “the next Solana gem,” walk away. The only thing growing here is the number of people who lost money.

The cryptocurrency market is full of real innovation - DeFi protocols with audited code, exchanges with millions of users, tokens with real revenue. Don’t waste your time on a ghost project with a fancy name and zero substance.

Biokript isn’t the future of crypto. It’s a warning sign.

Is Biokript (BKPT) a real cryptocurrency?

Technically, yes - it has a token address on the Solana blockchain. But it has no real market presence, no trading volume on major exchanges, and no verifiable team or technology. It’s a token in name only, not in function or value.

Can I buy Biokript on Binance or Coinbase?

No. Binance explicitly states that BKPT is not listed for trading or services. Coinbase doesn’t list it either. Any site claiming to sell BKPT on major exchanges is lying.

Why is the market cap $0?

Because no one is actively trading or holding the token in meaningful amounts. Market cap is calculated by multiplying price by circulating supply. If no tokens are circulating in real markets - or if exchanges report zero supply - the market cap becomes $0. That’s a sign the project is inactive or abandoned.

Is the 50/50 profit-sharing model legitimate?

No. Profit-sharing requires real trading fees. With only $27.86 in daily volume, the platform can’t generate enough fees to pay out 50% to anyone. The model is mathematically impossible with the current data. It’s a marketing lie.

Has Biokript been flagged as a scam?

Not officially by regulators - but major crypto platforms like Binance have issued warnings. Community sentiment across Reddit, Telegram, and CoinGecko is overwhelmingly negative. Users report being unable to redeem NFT credits, and no one has proof of profit payouts. These are classic signs of an exit scam.

Should I invest in Biokript?

Absolutely not. There is no upside. The token has no liquidity, no demand, no team transparency, and no future. Investing in BKPT is like buying a lottery ticket for a drawing that never happens. You’re not investing - you’re gambling on a dead project.

What should I do if I already bought BKPT?

If you bought BKPT during a presale or on a small DEX, your best option is to cut your losses. Selling now may mean getting a fraction of your investment back - but holding it won’t make it worth more. There’s no recovery path. Don’t throw good money after bad.

Is Biokript Shariah-compliant?

There is no evidence of certification from any Islamic finance authority. Claiming Shariah compliance without third-party verification is a common tactic in low-effort crypto projects to attract a specific audience. Treat this claim as marketing, not fact.

Why does Biokript claim to use Microsoft technology?

It’s a trust signal - but it’s fake. Microsoft doesn’t partner with obscure crypto tokens. There’s no official announcement, no Azure integration, and no technical documentation. This is a tactic used by scams to make their project look more credible than it is.

Is there any chance Biokript will recover?

Almost zero. Tokens with $0 market cap and $27 in daily volume don’t recover. They’re either abandoned or deliberately designed to be exit scams. Industry analysts say projects like this rarely last more than a few months after their all-time high. Biokript has already outlasted most - but that’s only because it was never real to begin with.